The Latest Breaking News from BristolMyers Squibb

Turn Bristol-Myers Squibb into an Income Machine with This Options Play

With markets coming in to a volatile time of year, investors might be more interested in generating income rather than capital gains.

Barchart · Aug 20

The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today

Bristol-Myers stock extends gains on reports of a potential merger with AstraZeneca. But caution is warranted in chasing the momentum in BMY shares today.

Barchart · Aug 3

Apple Could Swing $170 Billion In Value After Earnings

Earnings are back in the driver’s seat on Thursday, with a Benzinga-selected slate that ranges from regulated utilities to mega-cap tech and payments. With guidance and segment commentary often moving stocks as much as the headline numbers, the options market offers a real-time read on how much volatility traders are…

Benzinga · Jul 29

The Saturday Spread: Using the ‘Taxonomical’ Approach to Extract Profits

While fundamental and technical analyses dominate the finance ecosystem, there’s another, more powerful mechanism to succeed in the markets.

Barchart · Oct 18, 2025

ServiceNow, Live Nation Entertainment And A Health Care Stock: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, said ServiceNow, Inc. (NYSE:NOW) is around 25% off its 52-week high. It has become a victim of its own success, so it’s probably creating an attractive entry point, he added.

Benzinga · Aug 22, 2025

Bristol-Myers Squibb Stock: Is BMY Outperforming the Healthcare Sector?

Although Bristol-Myers Squibb has outshined relative to the healthcare sector over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart · Jun 4, 2025

Is BioNTech Stock a Buy on Major $11 Billion Cancer-Drug Deal?

With BioNTech sealing a blockbuster $11 billion cancer deal with Bristol-Myers Squibb, should investors be loading up on this rising biotech star?

Barchart · Jun 3, 2025

Did pharma sector dodge Trump’s tariffs? The EU's not so sure

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.

Euronews · Apr 3, 2025

Stocks Rise Before the Open With Focus on U.S. Economic Data and Amazon Earnings

March S&P 500 E-Mini futures (ESH25) are up +0.20%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.10% this morning, suggesting Wall Street is set to extend yesterday’s gains, while investors awaited a new round of U.S. economic data, remarks from Federal Reserve officials, and an earnings report from…

Barchart · Feb 6, 2025

Stocks Muted Before the Open With Focus on U.S. Economic Data and Amazon Earnings

March S&P 500 E-Mini futures (ESH25) are up +0.05%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.08% this morning as investors awaited a new round of U.S. economic data, remarks from Federal Reserve officials, and an earnings report from “Magnificent Seven” member Amazon.

Barchart · Feb 6, 2025